Graham Colditz | |
|---|---|
| Born | 1 November 1954 |
| Education | Newington College University of Queensland Harvard University |
| Occupation(s) | Niess-Gain Professor Washington University in St. Louis Associate Director Alvin J. Siteman Cancer Center |
| Spouse | Pat Cox |
| Children | 1 son, 1 daughter |
Graham Andrew Colditz MD, DrPH (born 1 November 1954) is an Australian chronic disease epidemiologist. He is the inaugural Niess-Gain Professor at Washington University School of Medicine, where he is associate director for Prevention and Control at the Alvin J. Siteman Cancer Center. [1] He directs the Master of Population Health Science at Washington University School of Medicine. [2] During medical training he was excited by the potential for prevention of chronic diseases. With encouragement from mentors he pursued training in the US as it was routine for academics in Australia to obtain overseas training at that time. He is internationally recognized for leadership in cancer prevention, [3] and is often interviewed by media for input on this topic. With members of Cancer Prevention and Control at Siteman, he blogs on issues relating to cancer prevention and screening. [4] According to Google Scholar statistics, Colditz has a h-index of more than 300. [5] Colditz was a member of the Institute of Medicine Committee to Review Adverse Effects of Vaccines but resigned, along with Ruby H. N. Nguyen, before it produced its seminal report. [6] In 2024, Colditz co-founded Prognosia Inc. with Shu (Joy) Jiang, with the goal of making their breast cancer prevention tool available to women and healthcare providers. [7] The technology received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) in June, 2025. [8]
Colditz was born in Australia and educated at Newington College (1967–72). [9] He was active in cricket and rugby at Newington. He received his B.Sc. and medical degree from the University of Queensland, Australia, where he served as President of the Australian Medical Students Association in 1977. He obtained his M.P.H. and Doctorate in Public Health from Harvard T.H. Chan School of Public Health. [10] Placing great importance on applying the scientific evidence amassed through research, Colditz has taken the lead on a number of large health communication projects, including the development of the long-running, popular health risk assessment, Your Disease Risk. [11] [12] At Siteman he leads efforts to promote cancer prevention in the community [13]
